These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25700349)

  • 41. TGF-beta1 and IFN-gamma cross-regulate antigen presentation to CD4 T cells by macrophages.
    Delvig AA; Lee JJ; Chrzanowska-Lightowlers ZM; Robinson JH
    J Leukoc Biol; 2002 Jul; 72(1):163-6. PubMed ID: 12101276
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor immune evasion arises through loss of TNF sensitivity.
    Kearney CJ; Vervoort SJ; Hogg SJ; Ramsbottom KM; Freeman AJ; Lalaoui N; Pijpers L; Michie J; Brown KK; Knight DA; Sutton V; Beavis PA; Voskoboinik I; Darcy PK; Silke J; Trapani JA; Johnstone RW; Oliaro J
    Sci Immunol; 2018 May; 3(23):. PubMed ID: 29776993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MHC class I down-regulation: tumour escape from immune surveillance? (review).
    Bubeník J
    Int J Oncol; 2004 Aug; 25(2):487-91. PubMed ID: 15254748
    [TBL] [Abstract][Full Text] [Related]  

  • 45. H2-M3-restricted CD8+ T cells augment CD4+ T-cell responses by promoting DC maturation.
    Chow MT; Teh HS
    Eur J Immunol; 2010 May; 40(5):1408-17. PubMed ID: 20162552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proteolysis-Targeting Chimeras Enhance T Cell Bispecific Antibody-Driven T Cell Activation and Effector Function through Increased MHC Class I Antigen Presentation in Cancer Cells.
    Massafra V; Tundo S; Dietzig A; Ducret A; Jost C; Klein C; Kontermann RE; Knoetgen H; Steegmaier M; Romagnani A; Nagel YA
    J Immunol; 2021 Jul; 207(2):493-504. PubMed ID: 34215653
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MHC class I down regulation, tumour escape from immune surveillance and design of therapeutic strategies.
    Bubeník J
    Folia Biol (Praha); 2005; 51(1):1-2. PubMed ID: 15783085
    [No Abstract]   [Full Text] [Related]  

  • 48. Integration of B cells and CD8+ T in the protective regulation of systemic epithelial inflammation.
    Wei B; McPherson M; Turovskaya O; Velazquez P; Fujiwara D; Brewer S; Braun J
    Clin Immunol; 2008 Jun; 127(3):303-12. PubMed ID: 18282744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumor Extracellular Matrix Stiffness Promptly Modulates the Phenotype and Gene Expression of Infiltrating T Lymphocytes.
    Chirivì M; Maiullari F; Milan M; Presutti D; Cordiglieri C; Crosti M; Sarnicola ML; Soluri A; Volpi M; Święszkowski W; Prati D; Rizzi M; Costantini M; Seliktar D; Parisi C; Bearzi C; Rizzi R
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple structural and epigenetic defects in the human leukocyte antigen class I antigen presentation pathway in a recurrent metastatic melanoma following immunotherapy.
    Chang CC; Pirozzi G; Wen SH; Chung IH; Chiu BL; Errico S; Luongo M; Lombardi ML; Ferrone S
    J Biol Chem; 2015 Oct; 290(44):26562-75. PubMed ID: 26381407
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The hemochromatosis protein HFE 20 years later: An emerging role in antigen presentation and in the immune system.
    Reuben A; Chung JW; Lapointe R; Santos MM
    Immun Inflamm Dis; 2017 Sep; 5(3):218-232. PubMed ID: 28474781
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFNγ receptor signaling.
    Marijt KA; Sluijter M; Blijleven L; Tolmeijer SH; Scheeren FA; van der Burg SH; van Hall T
    J Immunother Cancer; 2019 Jun; 7(1):152. PubMed ID: 31196219
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Direct recognition by alphabeta cytolytic T cells of Hfe, a MHC class Ib molecule without antigen-presenting function.
    Rohrlich PS; Fazilleau N; Ginhoux F; Firat H; Michel F; Cochet M; Laham N; Roth MP; Pascolo S; Nato F; Coppin H; Charneau P; Danos O; Acuto O; Ehrlich R; Kanellopoulos J; Lemonnier FA
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12855-60. PubMed ID: 16123136
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor surveillance: expression of the transporter associated with antigen processing (TAP-1) in ex-vivo human tumor samples and its elevation by in vitro treatment with IFN-gamma and TNF-alpha.
    Nagy N; Vánky F; Klein E
    Immunol Lett; 1998 Dec; 64(2-3):153-60. PubMed ID: 9870667
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pediatric Primitive Neuroectodermal Tumors of the Central Nervous System Differentially Express Granzyme Inhibitors.
    Vermeulen JF; van Hecke W; Spliet WG; Villacorta Hidalgo J; Fisch P; Broekhuizen R; Bovenschen N
    PLoS One; 2016; 11(3):e0151465. PubMed ID: 26963506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer.
    Burr ML; Sparbier CE; Chan KL; Chan YC; Kersbergen A; Lam EYN; Azidis-Yates E; Vassiliadis D; Bell CC; Gilan O; Jackson S; Tan L; Wong SQ; Hollizeck S; Michalak EM; Siddle HV; McCabe MT; Prinjha RK; Guerra GR; Solomon BJ; Sandhu S; Dawson SJ; Beavis PA; Tothill RW; Cullinane C; Lehner PJ; Sutherland KD; Dawson MA
    Cancer Cell; 2019 Oct; 36(4):385-401.e8. PubMed ID: 31564637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation.
    Dhatchinamoorthy K; Colbert JD; Rock KL
    Front Immunol; 2021; 12():636568. PubMed ID: 33767702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intratumoral Hypoxia Reduces IFN-γ-Mediated Immunity and MHC Class I Induction in a Preclinical Tumor Model.
    Murthy A; Gerber SA; Koch CJ; Lord EM
    Immunohorizons; 2019 Apr; 3(4):149-160. PubMed ID: 31356176
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Topoisomerase inhibitors modulate expression of melanocytic antigens and enhance T cell recognition of tumor cells.
    Haggerty TJ; Dunn IS; Rose LB; Newton EE; Martin S; Riley JL; Kurnick JT
    Cancer Immunol Immunother; 2011 Jan; 60(1):133-44. PubMed ID: 21052994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cultured human intrahepatic endothelial cells stimulate alloproliferative responses in highly purified CD4 and CD8+ T cells in vitro.
    Arvieux C; McNab G; Hathaway M; Adams DH
    Biochem Soc Trans; 1997 May; 25(2):256S. PubMed ID: 9191300
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.